Drug Chatter -- Tracking biopharma stock chatter

Profile for Oxford Immunotec Global PLC (OXFD)

« Back to company index

OXFD Chatter Timeline

Stock Ticker for OXFD

Most Active Tweeters for OXFD

UserTweets
@ConsumerFeed 6
@WeekHerald 5
@TickerReport 5
@WatchlistN 5
@TheMarketsDaily 4

Recent Tweets for OXFD

TickerReport @TickerReport
Critical Review: Oxford Immunotec Global $OXFD and Intellia Therapeutics $NTLA https://t.co/qY6VEgquzu
May 25th 2018, 5:05pm
WatchlistN @WatchlistN
Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD Will Announce Quarterly Sales of $28.55 Million https://t.co/Q0z1LYKXoe
May 25th 2018, 4:05pm
TickerReport @TickerReport
Oxford Immunotec Global $OXFD Rating Increased to Buy at BidaskClub https://t.co/IsFNt85gzb
May 25th 2018, 12:05pm
ConsumerFeed @ConsumerFeed
Oxford Immunotec Global $OXFD Raised to “Hold” at Zacks Investment Research https://t.co/rkEA0LCpup
May 25th 2018, 12:05pm
ledgerzette @ledgerzette
$28.55 Million in Sales Expected for Oxford Immunotec Global PLC $OXFD This Quarter https://t.co/2EpNgOilB6
May 25th 2018, 11:05am
registrarjourn @registrarjourn
Oxford Immunotec Global $OXFD Raised to “Hold” at Zacks Investment Research https://t.co/wCZABhcHUA
May 25th 2018, 7:05am
WeekHerald @WeekHerald
Critical Analysis: Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD https://t.co/gTVJ2jxZc9
May 24th 2018, 5:05pm
TranscriptDaily @TranscriptDaily
Critical Analysis: Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD https://t.co/pi1mmzxG7V
May 24th 2018, 5:05pm
TheMarketsDaily @TheMarketsDaily
Oxford Immunotec Global $OXFD Rating Increased to Hold at Zacks Investment Research https://t.co/QHthlxbSvk
May 24th 2018, 7:05am
WeekHerald @WeekHerald
Oxford Immunotec Global $OXFD Rating Increased to Hold at Zacks Investment Research https://t.co/bssSCtdktQ
May 24th 2018, 6:05am
dailypoliticaln @dailypoliticaln
Oxford Immunotec Global $OXFD Stock Rating Upgraded by BidaskClub https://t.co/34tGEx3LfY
May 24th 2018, 5:05am
ConsumerFeed @ConsumerFeed
Research Analysts’ Recent Ratings Updates for Oxford Immunotec Global $OXFD https://t.co/InLVQM9Ds0
May 23rd 2018, 2:05pm
ledgerzette @ledgerzette
Oxford Immunotec Global $OXFD Upgraded to “Buy” at BidaskClub https://t.co/SFhylMZtVl
May 23rd 2018, 6:05am
TickerReport @TickerReport
-$0.24 Earnings Per Share Expected for Oxford Immunotec Global PLC $OXFD This Quarter https://t.co/FPHJDtgPw7
May 23rd 2018, 5:05am
ConsumerFeed @ConsumerFeed
Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD to Announce -$0.24 EPS https://t.co/eLGXOgkskk
May 23rd 2018, 5:05am
ConsumerFeed @ConsumerFeed
Oxford Immunotec Global $OXFD Upgraded to “Buy” at BidaskClub https://t.co/Uo2XBJ6CBW
May 23rd 2018, 5:05am
WatchlistN @WatchlistN
Oxford Immunotec Global $OXFD Upgraded to Hold at Zacks Investment Research https://t.co/mbMNGNKKzs
May 23rd 2018, 4:05am
WatchlistN @WatchlistN
Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD Head-To-Head Analysis https://t.co/ve6KB81SE9
May 23rd 2018, 4:05am
TickerReport @TickerReport
Oxford Immunotec Global $OXFD Upgraded to Hold at Zacks Investment Research https://t.co/VNb4h7tWb7
May 23rd 2018, 4:05am
odibro @odibro
$OXFD Announces Launch of the Accutix™ Brand for its tick- borne disease offering https://t.co/rWfmlMfwaM
May 22nd 2018, 8:05am
stockelite @stockelite
$OXFD Oxford Immunotec Announces Launch of the Accutix™ Brand https://t.co/XNaCw8yZHQ
May 22nd 2018, 8:05am
GNWLive @GNWLive
Oxford Immunotec Announces Launch of the Accutix™ Brand $OXFD https://t.co/faItbTFbR5
May 22nd 2018, 8:05am
dakotafinancial @dakotafinancial
Oxford Immunotec Global $OXFD Raised to Buy at BidaskClub https://t.co/hlTFXdRcLn
May 22nd 2018, 7:05am
TheMarketsDaily @TheMarketsDaily
Oxford Immunotec Global $OXFD Raised to Buy at BidaskClub https://t.co/RM0b8wlCa6
May 22nd 2018, 7:05am
ZolmaxNews @ZolmaxNews
Zacks Investment Research Upgrades Oxford Immunotec Global $OXFD to Hold https://t.co/qScFPuEfpV
May 22nd 2018, 6:05am
dailypoliticaln @dailypoliticaln
Zacks Investment Research Upgrades Oxford Immunotec Global $OXFD to Hold https://t.co/v8uFJfHusk
May 22nd 2018, 6:05am
AmericanBanking @AmericanBanking
Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $28.55 Million https://t.co/GUZOzyYhZE #stocks
May 22nd 2018, 2:05am
TickerReport @TickerReport
Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $28.55 Million https://t.co/aHUczxTAvb
May 22nd 2018, 2:05am
dailypoliticaln @dailypoliticaln
Oxford Immunotec Global PLC $OXFD Expected to Announce Quarterly Sales of $28.55 Million https://t.co/VNAABMx1kG
May 22nd 2018, 2:05am
stockelite @stockelite
$OXFD Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential Diagnosti… https://t.co/gg2eYpXe4d
May 21st 2018, 4:05pm
portefeuillefun @portefeuillefun
RT @GNWLive: Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential $OXFD https://t.co/i9R5O6Q…
May 21st 2018, 4:05pm
GNWLive @GNWLive
Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential $OXFD https://t.co/i9R5O6QBBU
May 21st 2018, 4:05pm
AmericanBanking @AmericanBanking
Brokerages Anticipate Oxford Immunotec Global PLC $OXFD to Announce -$0.24 Earnings Per Share https://t.co/tT7zc1ZH6B #stocks
May 20th 2018, 7:05pm
WatchlistN @WatchlistN
Zacks: Analysts Anticipate Oxford Immunotec Global PLC $OXFD Will Announce Earnings of -$0.24 Per Share https://t.co/7rwVQ04TDG
May 20th 2018, 7:05pm
ThisLincolnian @ThisLincolnian
Brokerages Anticipate Oxford Immunotec Global PLC $OXFD to Announce -$0.24 Earnings Per Share https://t.co/px39Cmz6YD
May 20th 2018, 7:05pm
WeekHerald @WeekHerald
Financial Contrast: Intellia Therapeutics $NTLA versus Oxford Immunotec Global $OXFD https://t.co/lgE09wDWdF
May 20th 2018, 6:05am
AmericanBanking @AmericanBanking
Financial Contrast: Intellia Therapeutics $NTLA versus Oxford Immunotec Global $OXFD https://t.co/3RQDviy5wB #stocks
May 20th 2018, 1:05am
ConsumerFeed @ConsumerFeed
Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD Head to Head Analysis https://t.co/Q4lfGcL96P
May 20th 2018, 1:05am
GNWLive @GNWLive
Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference $OXFD https://t.co/qopvPEFgIw
May 16th 2018, 9:05am
ConsumerFeed @ConsumerFeed
Oxford Immunotec Global $OXFD Downgraded to “Hold” at BidaskClub https://t.co/pMG4pjvfk6
May 15th 2018, 4:05am
ZolmaxNews @ZolmaxNews
Oxford Immunotec Global $OXFD Downgraded to “Hold” at BidaskClub https://t.co/MKDHMgZrPu
May 15th 2018, 4:05am
dispatchtribune @dispatchtribune
BidaskClub Downgrades Oxford Immunotec Global $OXFD to Hold https://t.co/4anqy7Q0M0
May 14th 2018, 11:05am
OlympiaReport @OlympiaReport
Oxford Immunotec Global $OXFD Stock Rating Lowered by BidaskClub https://t.co/aExzDNqgg8
May 13th 2018, 2:05pm
TheMarketsDaily @TheMarketsDaily
Oxford Immunotec Global $OXFD Earning Somewhat Positive Press Coverage, Report Shows https://t.co/AkJpc1k4Q0
May 13th 2018, 2:05pm
dakotafinancial @dakotafinancial
Somewhat Positive News Coverage Somewhat Unlikely to Affect Oxford Immunotec Global $OXFD Share Price https://t.co/ZngSXa8HBC
May 13th 2018, 2:05pm
EnterpriseLeade @EnterpriseLeade
$28.55 Million in Sales Expected for Oxford Immunotec Global $OXFD This Quarter https://t.co/kCmCEoHzs8
May 12th 2018, 9:05pm
ThisLincolnian @ThisLincolnian
Zacks: Analysts Anticipate Oxford Immunotec Global $OXFD Will Announce Quarterly Sales of $28.55 Million https://t.co/pxCIBR0eaX
May 12th 2018, 9:05pm
dakotafinancial @dakotafinancial
Oxford Immunotec Global $OXFD Given Average Recommendation of “Hold” by Analysts https://t.co/BDG9obX8tL
May 12th 2018, 8:05pm
WeekHerald @WeekHerald
Oxford Immunotec Global $OXFD Given Average Recommendation of “Hold” by Analysts https://t.co/wdyTcfiY2D
May 12th 2018, 8:05pm
TheMarketsDaily @TheMarketsDaily
Oxford Immunotec Global $OXFD Receives $18.25 Average PT from Brokerages https://t.co/2zogazG75x
May 12th 2018, 8:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.